IB [email protected] ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California ST. PAUL, Minn., Sept. 9, 2025 - ScaleReady, in collaboration ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Elcogen, the Estonian pioneer in fuel cell technology, just flipped the switch on a game-changing plant in Tallinn. On ...

The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...

DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

Automated cell manufacturing company Mytos has signed an agreement with Aspen Neuroscience, a clinical-stage private company focused on autologous regenerative medicine, to automate the manufacture of ...